Glycoprotein IIb/IIIa inhibitors and no-reflow.
Kloner
Robert A
RA
Heart Institute, Good Samaritan Hospital, Los Angeles, California 90017, USA. rkloner@goodsam.org
Dai
Wangde
W
D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008833:Microcirculation / Q000187:drug effects*; D023421:Models, Animal; D009203:Myocardial Infarction / Q000188:drug therapy; D015425:Myocardial Reperfusion / Q000379:methods; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015427:Reperfusion Injury / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014654:Vascular Patency / Q000187:drug effects
D005343:Fibrinolytic Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D000077466:Tirofiban